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ABSTRACT
The aim of this study was to investigate the patterns and dynamics of the microbiota in the airways of
ventilated patients. Seventy-four mechanically-ventilated patients were recruited consecutively, and
oropharyngeal, tracheal and bronchoalveolar (BAL) fluid specimens were collected 48 h after intubation,
and every 72 h thereafter until the patient was extubated or a total of five sample sets had been collected.
Ventilator-associated pneumonia (VAP) pathogens were identified, quantified and genotyped. Microbial
findingswere highly correlated both between airway locations and over timewhen sampleswere taken no
more than 72 h apart. If noVAPpathogenwaspresent in the oral flora, itwasunlikely to be found in a lower
airway sample; i.e., the positive predictive value of the oropharyngeal samplewas 0.73 (95% CI 0.67–0.80),
and the negative predictive value was 0.95 (95% CI 0.92–0.99). Colonisation with Enterobacteriacae, non-
fermentative bacteria and Staphylococcus aureus was monoclonal in the airways and over time, whereas
colonisation with microbes normally found in the oropharynx, i.e., Haemophilus influenzae, Haemophilus
parainfluenzae and Streptococcus pneumoniae, was polyclonal. When antibiotics were used, the chance of
recovering VAP pathogens from all sampling sites was reduced three-fold. No correlation was observed
between a bacterial count of ‡104 CFU ⁄mL in BAL fluid and chest X-rays compatible with VAP.
Keywords Airway colonisation, colonisation, genotyping, mechanical ventilation, surveillance, ventilator-associ-
ated pneumonia
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INTRODUCTION
Quantitative microbiological cultures of the low-
er airways are often recommended for diagnosis
and treatment decisions in cases of ventilator-
associated pneumonia (VAP) [1]. Differentiation
between colonisation and infection of the lower
airways is based primarily on quantitative cul-
ture, with defined thresholds for each condition.
However, the validity of this diagnostic app-
roach remains controversial [2–4]. Knowledge of
the normal colonisation patterns throughout the
airways of ventilated patients is important in
assessing the usefulness of obtaining microbio-
logical cultures from the lower airways for
establishing the diagnosis of VAP, as well as
for guiding antimicrobial therapy. Serial samp-
ling of specimens from different levels of the
airways allows the evolution of the microbiota to
be studied over space and time, and is therefore
of particular interest. However, there is a paucity
of such studies [5–9] and, to our knowledge,
none which includes systematic genotyping of
isolates. The objective of the present study was
to examine the colonisation patterns and dynam-
ics of the microbiota in the airways during the
course of stay in an intensive care unit (ICU) for
a non-selected general ICU population ventilated
for >48 h.
MATERIALS AND METHODS
Akershus University Hospital, Nordbyhagen, Norway is a
secondary referral hospital with a combined medical and
surgical ICUwith ten beds. All specialties except neurosurgery,
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heart surgery and transplant surgery are covered. The majority
of patients admitted to the ICU are in need of ventilator
support.
The study was approved by the regional ethical committee
of eastern Norway. During four periods of 2–4 months
between 25 April 2001 and 1 June 2004, eligible patients were
recruited consecutively for extensive microbial surveillance of
their airways. Inclusion criteria were an age >18 years and
admission to the ICU with any diagnosis other than pneu-
monia, and with an expected need for ventilator support of
>48 h. Seventy-four patients were included, of whom 40 were
females; the median age was 61 (range 23–83) years, the
median Simplified Acute Physiology score II (SAPS II) was 50
(range 20–77), and the median length of ventilator support was
9 (range 3–149) days. Twenty-one (28%) patients died while in
the ICU, and another nine patients died in hospital following
ICU discharge (in-hospital mortality rate of 41%).
A sample set, comprising an oropharyngeal swab, a
tracheal suction sample, and a blind bronchoalveolar lavage
(BAL) sample, was taken 48 h after intubation, and every 72 h
thereafter until the patient was extubated, or a total of five
sample sets had been taken. The blind BAL sample was taken
by inserting a protected double-lumen catheter (COMBICATH
58124 40; Plastimed, Saint Leu La Foret, France) through the
oral tube or tracheostoma to a wedge position in the bronchial
tree, instilling 60 mL of saline, and then immediately with-
drawing the fluid. The tracheal suction was performed by
inserting a sterile suctioning catheter through the oral tube or
tracheostoma, instilling 20 mL of saline, and then immediately
withdrawing the fluid.
Oropharyngeal swabs, tracheal samples and BAL samples
were cultured aerobically on standard microbiological media.
Identification and quantification of VAP pathogens [10] were
performed using standard techniques. Bacterial DNA was
extracted using a MagAttract DNA Mini M48 Kit (Qiagen,
Valencia, CA, USA).
Amplified fragment length polymorphism analysis was the
method of choice for genotyping all bacterial species, except
for Staphylococcus aureus. Amplified fragment length poly-
morphism analysis was performed as described previously
[11] using a 3130xl Genetic Analyzer and an amplified
fragment length polymorphism Microbial Fingerprinting Kit
(Applied Biosystems, Foster City, CA, USA). Staph. aureus
isolates were genotyped by multilocus sequence typing and
spa (staphylococcal protein A gene) typing as described
previously [12], using the modifications published in the
multilocus sequence typing Application Note from Applied
Biosystems (http://docs.appliedbiosystems.com/pebiodocs/
00114960.pdf).
The date of initiation of antibiotic therapy, the types of
antibiotic and the date of withdrawal of therapy were recorded
for all patients. A senior radiologist, blinded to both patient
and microbiological data, reassessed all chest X-rays taken
before admission and during the sampling period. Serial
radiographs were available for all patients who had more than
one microbiological sample taken. Only infiltrates that were
present consistently on subsequent X-rays, i.e., not transient,
were considered to be of pneumonic origin. When available,
chest computerised tomography scans were used to confirm
the diagnosis.
The Phi Cramer V-test for nominal data without intrinsic
order was used for correlation analysis. All tests were
performed using SPSS software (SPSS Inc., Chicago, IL, USA).
RESULTS
Seventy-four patients were enrolled, with a sec-
ond sample set obtained from 47 patients, a third
from 28 patients, a fourth from 16 patients, and a
fifth from 13 patients, after 5, 8, 11 and 14 days,
respectively. In total, 181 oropharyngeal, 181
tracheal and 179 BAL samples were taken. BAL
fluid yielding bacterial counts of ‡104 CFU ⁄mL of
a VAP pathogen was obtained from 42 of 74
patients.
The distribution of isolates in the oropharynx
and BAL fluid during the early period of venti-
lation (sample set 1) vs. intermediate (sample sets
2 and 3) and late (sample sets 4 and 5) periods is
shown in Fig. 1. With the exception of a relative
increase in the isolation rate for Candida spp. in
the oropharyngeal samples, only minor changes
in pattern were apparent over time.
There were strong correlations between the
microbial findings and sampling sites on the same
sampling day, with coefficients ranging from 0.74
between oropharyngeal and BAL samples, to 0.92
between tracheal and BAL samples. Correlations
over time ranged between 0.71 and 0.88 when
samples were taken £72 h apart. More than one
VAP pathogen was recovered from 16 BAL
samples and 36 oropharyngeal samples.
Correlating only oropharyngeal and BAL sam-
ples with VAP pathogens, i.e., not including
samples with Candida spp. and normal oropha-
ryngeal flora, nine (5%) of 179 BAL samples
harboured a VAP pathogen that was not found in
the oropharyngeal sample (95% CI 1.8–8.2). For
two of these nine pairs, the oropharyngeal sample
harboured normal microbiota, while the remain-
ing seven contained at least one VAP pathogen
that differed from the pathogen isolated from the
BAL sample. The negative predictive value of a
VAP pathogen in an oropharyngeal sample with
respect to its simultaneous presence in a BAL
sample was accordingly 0.95 (95% CI 0.92–0.99).
The corresponding positive predictive value was
0.73 (95% CI 0.67–0.80).
Genotyping showed a unique clone in individ-
ual patients for Escherichia coli, Pseudomonas aeru-
ginosa, Stenotrophomonas maltophilia, Acinetobacter
spp., Citrobacter spp., Enterobacter spp., Klebsiella
spp., Streptococcus milleri, Proteus mirabilis, group
B streptococci and Staph. aureus. Ps. aeruginosa
was monoclonal in individual patients, but the
same clone was found in ten colonised patients
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because of an outbreak caused by contaminated
oral swabs that occurred during the sampling
period [13]. A heterogeneous microbial popula-
tion was found when patients were colonised
with Haemophilus influenzae (heterogeneous in six
of 14 patients), Haemophilus parainfluenzae (three of
eight), Streptococcus pneumoniae (two of five) or
enterococci (one of six). In 17 patients, genotyp-
ically identical isolates were found on at least
three occasions separated by 6 days.
The number of patients receiving antibiotics
ranged from 40 (54%) of 74 on the first sampling
day, to seven (64%) of 11 on the last day. Growth
of ‡104 CFU ⁄mL of a VAP pathogen in BAL fluid
was found for six of 40 patients receiving appro-
priate antibiotics on the first sampling day,
compared with 16 of 33 for those not receiving
antibiotics (OR 0.31; 95% CI 0.11–0.91). Similar
results were found on days 5, 8 and 11.
On the first day of sampling, 18 patients had
new lobar or patchy chest X-ray infiltrates, which
did not disappear on subsequent X-rays and were
considered to be consistent with pneumonia.
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occurred from the BAL fluid of five of these
patients; the BAL fluid of the remaining 55
patients without X-ray infiltrates yielded growth
of a relevant pathogen (>104 CFU ⁄mL) in 20
cases. On the second sampling day, another four
patients had new chest X-ray infiltrates compat-
ible with pneumonia, but none on later sampling
days.
DISCUSSION
The main outcome of this study was the finding of
a high correlation between the growth of VAP
pathogens in the oropharynx, tracheal secretions
and BAL fluid on the same day of sampling, as
well as on subsequent sampling days, when these
are separated by £72 h. Importantly, these corre-
lations were also present at the genomic level.
Concordance between findings in tracheal and
BAL samples was found in a previous study [14].
However, the present study showed that it was
possible to isolate those pathogens from the oral
flora that will be found in the distal airways either
on the same sampling day or on subsequent
sampling days for up to 72 h; i.e., the positive
predictive value of an oropharyngeal swab was
73% and the negative predictive value was 95%.
According to the protocol, sampling of BAL
fluid was carried out before tracheal sampling.
Some degree of regurgitation of the instilled BAL
fluid into the trachea is unavoidable, and the high
correlation between findings in the tracheal and
BAL fluid may, in part, be explained by mixing of
the two fluids. However, this was not the case
with the oropharyngeal samples, as the catheters
were introduced through an adapter in the oro-
tracheal or tracheostomy tubes, and never came in
contact with the oropharynx. The high correlation
between findings in oropharyngeal and BAL ⁄ tra-
cheal samples is therefore without bias, and
suggests that the upper and lower airways in
ventilated patients are colonised simultaneously
or in a rapid sequence (£48 h) with the same VAP
pathogens.
Surveillance cultures of ventilated patients are
controversial. Twice-weekly endotracheal sur-
veillance cultures have been found to identify
pathogens when VAP was suspected [15]. Ha-
yon et al. [6] did not recommend this strategy,
but the median time from collection of airway
secretions to the VAP episode was 8 days. The
present study shows that this is too long, since
the correlation with subsequent samplings
decreases after 72 h. Furthermore, the reluctance
of clinicians to conduct semi-invasive proce-
dures for surveillance purposes probably limits
the possibility of regular sampling, and thus its
clinical usefulness. In contrast, oropharyngeal
cultures are easy to obtain, and the high
correlation between oropharyngeal and BAL
samples with respect to VAP pathogens makes
an oropharyngeal swab worth considering for
surveillance purposes [16,17].
The genotyping results showed that, with the
exception of one patient who was colonised with
two different clones of Prot. mirabilis, colonisation
with Staph. aureus or members of the Enterobac-
teriacae family was monoclonal in individual
patients. This is in contrast to colonisation pat-
terns with H. influenzae, H. parainfluenzae and
Strep. pneumoniae, which revealed a heterogene-
ous population with multiple clones in the distal
samples of individual patients. Colonisation of
the distal airways by the latter species is common,
especially in patients with chronic obstructive
lung disease [18]. This polyclonality may indicate
a more permanent state of colonisation, whereas
monoclonality could represent more recent colo-
nisation with bacteria less adapted to the airways.
No significant correlation was found between
growth of ‡104 CFU ⁄mL from BAL fluid and
chest X-ray infiltrates compatible with VAP.
Differences in the use of antibiotics among
patients with and without chest X-ray infiltrates
could not explain the absence of any correlation,
as the proportions of patients receiving antibiotics
who yielded growth of ‡104 CFU ⁄mL of a VAP
pathogen were the same in the groups with and
without infiltrates (nine of 18 and 12 of 20,
respectively). Accepting that new or progressive
chest X-ray infiltrates compatible with pneumonia
are mandatory for the diagnosis of VAP [19], the
specificity of the criterion specifying growth of
‡104 CFU ⁄mL seems poor, as has been observed
previously [14]. The sensitivity of plate counts is
not very high and could contribute to the poor
correlation; however, this problem applies to all
similar studies.
In conclusion, the microbiota in the upper and
lower airways of mechanically-ventilated patients
are closely correlated and relatively stable over a
period of 72 h. Oropharyngeal swab surveillance
cultures may therefore help to guide initial
therapy in cases of suspected VAP.
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